{"protocolSection": {"identificationModule": {"nctId": "NCT01864174", "orgStudyIdInfo": {"id": "CV181-206"}, "secondaryIdInfos": [{"id": "2012-004531-23", "type": "EUDRACT_NUMBER"}], "organization": {"fullName": "Bristol-Myers Squibb", "class": "INDUSTRY"}, "briefTitle": "Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes", "officialTitle": "A 24-Week International, Multi-center, Randomized, Parallel-group, Double-blind Trial to Evaluate Metformin Extended Release Monotherapy Compared to Metformin Immediate Release Monotherapy in Adults Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise"}, "statusModule": {"statusVerifiedDate": "2019-11", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2013-06-20", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2016-06-01", "type": "ACTUAL"}, "completionDateStruct": {"date": "2016-06-01", "type": "ACTUAL"}, "studyFirstSubmitDate": "2013-05-24", "studyFirstSubmitQcDate": "2013-05-24", "studyFirstPostDateStruct": {"date": "2013-05-29", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2017-05-31", "resultsFirstSubmitQcDate": "2017-06-23", "resultsFirstPostDateStruct": {"date": "2017-07-21", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2019-11-26", "lastUpdatePostDateStruct": {"date": "2019-11-29", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Bristol-Myers Squibb", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": false, "isFdaRegulatedDrug": true, "isFdaRegulatedDevice": false}, "descriptionModule": {"briefSummary": "The purpose of this study is determine if Metformin XR monotherapy in subjects with type 2 diabetes is non-inferior to Metformin IR monotherapy"}, "conditionsModule": {"conditions": ["Type 2 Diabetes Mellitus"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE4"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "DOUBLE", "whoMasked": ["PARTICIPANT", "INVESTIGATOR"]}}, "enrollmentInfo": {"count": 1736, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Arm 1: Metformin XR and Placebo matching with Metformin XR", "type": "ACTIVE_COMPARATOR", "description": "Metformin Extended Release (XR) 500 mg tablets (500-2000 mg per day) by mouth twice daily (BID) for 24 weeks\n\nPlacebo matching with Metformin XR 0 mg tablets by mouth twice daily (BID) for 24 weeks", "interventionNames": ["Drug: Metformin XR", "Drug: Placebo matching with Metformin XR"]}, {"label": "Arm 2: Metformin IR and Placebo matching with Metformin IR", "type": "ACTIVE_COMPARATOR", "description": "Metformin Immediate Release (IR) 500 mg tablets (500-2000 mg per day) by mouth twice daily (BID) for 24 weeks\n\nPlacebo matching with Metformin IR 0 mg tablets by mouth twice daily (BID) for 24 weeks", "interventionNames": ["Drug: Metformin IR", "Drug: Placebo matching with Metformin IR"]}], "interventions": [{"type": "DRUG", "name": "Metformin XR", "armGroupLabels": ["Arm 1: Metformin XR and Placebo matching with Metformin XR"], "otherNames": ["Glucophage XR"]}, {"type": "DRUG", "name": "Metformin IR", "armGroupLabels": ["Arm 2: Metformin IR and Placebo matching with Metformin IR"], "otherNames": ["Glucophage"]}, {"type": "DRUG", "name": "Placebo matching with Metformin XR", "armGroupLabels": ["Arm 1: Metformin XR and Placebo matching with Metformin XR"]}, {"type": "DRUG", "name": "Placebo matching with Metformin IR", "armGroupLabels": ["Arm 2: Metformin IR and Placebo matching with Metformin IR"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Adjusted Mean Change From Baseline in HbA1c", "description": "Mean change in glycated hemoglobin (HbA1c) from baseline to Week 24 in the double-blind treatment period.", "timeFrame": "Baseline and Week 24"}, {"measure": "Number of Participants With Death, Serious Adverse Events (SAEs), SAEs Related to Study Therapy, SAEs Leading to Discontinuation, Adverse Events (AEs) Related to Study Therapy, and AEs Leading to Discontinuation", "description": "SAE=a medical event that at any dose results in death, persistent or significant disability/incapacity, or drug dependency/abuse; is life-threatening, an important medical event, or a congenital anomaly/birth defect; or requires or prolongs hospitalization. AE=any new unfavorable symptom, sign, or disease or worsening of a preexisting condition that may not have a causal relationship with treatment. Treatment-related=having certain, probable, possible, or missing relationship to study drug. All listed events are treatment emergent, which is defined as nonserious and serious AEs with an onset from Day 1 of the double-blind treatment up to and including 4 days and 30 days respectively, after the last dose date of double-blind study. randomized.", "timeFrame": "Date of first dose (Day 1) up to 30 post last dose of study drug (approx. 28 weeks)"}], "secondaryOutcomes": [{"measure": "Mean Change in Fasting Plasma Glucose (FPG)", "description": "The mean change in fasting plasma glucose (FPG) from baseline to Week 24 in the double-blind treatment period was assessed. The lack of glycemic control criteria for initiation of rescue medication during Week 12 to Week 24 was having a FPG \\> 200 mg/dL (11.1 mmol/L). mg/dL = milligrams per deciliter; mmol/L = millimole per Liter", "timeFrame": "Baseline and Week 24"}, {"measure": "Mean Change in Mean Daily Glucose (MDG)", "description": "The mean change in Mean Daily Glucose (MDG) from baseline to Week 24 in the double-blind treatment period was assessed. Prior to the Day 1 visit (between Week -1 and Day 1) and in the week before the Week 24/Study Termination and Rescue or Early Treatment Termination visit, participants performed 7-point finger stick blood glucose monitoring (before and 2 hours after 3 meals per day, and at bedtime) for 3 consecutive days in order to determine their MDG.", "timeFrame": "Baseline and Week 24"}, {"measure": "Percent of Participants With HbA1c < 7%", "description": "Percent of participants achieving a therapeutic glycemic response (defined as HbA1c \\< 7.0%) at Week 24 in the double-blind treatment period.", "timeFrame": "Week 24"}]}, "eligibilityModule": {"eligibilityCriteria": "For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com\n\nInclusion Criteria:\n\n* Men and women, aged \u226518 years old at time of enrollment\n* Treatment naive subjects with type 2 diabetes mellitus with inadequate glycemic (HbA1c \u22657.0% and \u22649.2% obtained at screening visit) control on diet and exercise alone\n* Women must have a negative serum or urine test within 24 hours prior to start of investigational product\n\nExclusion Criteria:\n\n* History of ketoacidosis, lactic acidosis or hyperosmolar non-ketonic coma\n* Symptoms of poorly controlled diabetes, including but not limited to marked polyuria and polydipsia with \\>10% weight loss during last 3 months\n* Serum creatinine \u22651.50 mg/dL (133 \u03bcmol/L) for male subjects; serum creatinine \u22651.40 mg/dL (124 \u03bcmol/L for female subjects)", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Bristol-Myers Squibb", "affiliation": "Bristol-Myers Squibb", "role": "STUDY_DIRECTOR"}], "locations": [{"facility": "Central Alabama Research", "city": "Birmingham", "state": "Alabama", "zip": "35209", "country": "United States", "geoPoint": {"lat": 33.52066, "lon": -86.80249}}, {"facility": "Terence T. Hart, Md", "city": "Muscle Shoals", "state": "Alabama", "zip": "35662", "country": "United States", "geoPoint": {"lat": 34.74481, "lon": -87.66753}}, {"facility": "Clini Res Advantage Desert Clin Res, Llc", "city": "Mesa", "state": "Arizona", "zip": "85213", "country": "United States", "geoPoint": {"lat": 33.42227, "lon": -111.82264}}, {"facility": "Clinical Res Advantage Central", "city": "Phoenix", "state": "Arkansas", "zip": "85020", "country": "United States"}, {"facility": "Marin Endocrine Care And Research, Inc.", "city": "Greenbrae", "state": "California", "zip": "94904", "country": "United States", "geoPoint": {"lat": 37.94854, "lon": -122.5247}}, {"facility": "Torrance Clinical Research Institute Inc.", "city": "Lomita", "state": "California", "zip": "90717", "country": "United States", "geoPoint": {"lat": 33.79224, "lon": -118.31507}}, {"facility": "Actca", "city": "Los Angeles", "state": "California", "zip": "90017", "country": "United States", "geoPoint": {"lat": 34.05223, "lon": -118.24368}}, {"facility": "National Research Institute", "city": "Los Angeles", "state": "California", "zip": "90057", "country": "United States", "geoPoint": {"lat": 34.05223, "lon": -118.24368}}, {"facility": "R. Srinivasan, M.D., Inc.", "city": "Monterey Park", "state": "California", "zip": "91754", "country": "United States", "geoPoint": {"lat": 34.06251, "lon": -118.12285}}, {"facility": "Diabetes Medical Center Of California", "city": "Northridge", "state": "California", "zip": "91325", "country": "United States", "geoPoint": {"lat": 34.22834, "lon": -118.53675}}, {"facility": "Valley Clinical Trials", "city": "Northridge", "state": "California", "zip": "91325", "country": "United States", "geoPoint": {"lat": 34.22834, "lon": -118.53675}}, {"facility": "Center For Clinical Trials Of Sacramento, Inc.", "city": "Sacramento", "state": "California", "zip": "95823", "country": "United States", "geoPoint": {"lat": 38.58157, "lon": -121.4944}}, {"facility": "Clinical Research Advantage", "city": "Colorado Springs", "state": "Colorado", "zip": "80906", "country": "United States", "geoPoint": {"lat": 38.83388, "lon": -104.82136}}, {"facility": "Clinical Research Advantage", "city": "Colorado Springs", "state": "Colorado", "zip": "80909", "country": "United States", "geoPoint": {"lat": 38.83388, "lon": -104.82136}}, {"facility": "Colorado Springs Family Practice", "city": "Colorado Springs", "state": "Colorado", "zip": "80909", "country": "United States", "geoPoint": {"lat": 38.83388, "lon": -104.82136}}, {"facility": "Clinical Research Advantage, Inc/Co Springs Health Partners, Briar", "city": "Colorado Springs", "state": "Colorado", "zip": "80920", "country": "United States", "geoPoint": {"lat": 38.83388, "lon": -104.82136}}, {"facility": "Solutions Through Advanced Research, Inc.", "city": "Jacksonville", "state": "Florida", "zip": "32258", "country": "United States", "geoPoint": {"lat": 30.33218, "lon": -81.65565}}, {"facility": "Family Care Partners", "city": "Jacksonville", "state": "Florida", "zip": "32277", "country": "United States", "geoPoint": {"lat": 30.33218, "lon": -81.65565}}, {"facility": "Omega Research Consultants, Llc", "city": "Orlando", "state": "Florida", "zip": "32804", "country": "United States", "geoPoint": {"lat": 28.53834, "lon": -81.37924}}, {"facility": "Palm Harbor Medical Associates", "city": "Palm Harbor", "state": "Florida", "zip": "34684", "country": "United States", "geoPoint": {"lat": 28.07807, "lon": -82.76371}}, {"facility": "Gulfcoast Medical Research Center, Llc", "city": "Tampa", "state": "Florida", "zip": "33607", "country": "United States", "geoPoint": {"lat": 27.94752, "lon": -82.45843}}, {"facility": "Cedar-Crosse Research Ctr", "city": "Chicago", "state": "Illinois", "zip": "60607", "country": "United States", "geoPoint": {"lat": 41.85003, "lon": -87.65005}}, {"facility": "Clinical Research Advantage, Inc./Family Medicine Associates", "city": "Evansville", "state": "Indiana", "zip": "47725", "country": "United States", "geoPoint": {"lat": 37.97476, "lon": -87.55585}}, {"facility": "American Health Network Of In Llc", "city": "Muncie", "state": "Indiana", "zip": "47304", "country": "United States", "geoPoint": {"lat": 40.19338, "lon": -85.38636}}, {"facility": "Columbia Medical Practice", "city": "Columbia", "state": "Maryland", "zip": "21045", "country": "United States", "geoPoint": {"lat": 39.24038, "lon": -76.83942}}, {"facility": "Centennial Medical Group", "city": "Elkridge", "state": "Maryland", "zip": "21075", "country": "United States", "geoPoint": {"lat": 39.21261, "lon": -76.71358}}, {"facility": "Drs. Rodbard And Dempsey", "city": "Rockville", "state": "Maryland", "zip": "20852", "country": "United States", "geoPoint": {"lat": 39.084, "lon": -77.15276}}, {"facility": "Ny Clinical Trials", "city": "New York", "state": "New York", "zip": "10018", "country": "United States", "geoPoint": {"lat": 40.71427, "lon": -74.00597}}, {"facility": "White Oak Family Physicians, Pa", "city": "Asheboro", "state": "North Carolina", "zip": "27203", "country": "United States", "geoPoint": {"lat": 35.70791, "lon": -79.81364}}, {"facility": "Metrolina Internal Medicine", "city": "Charlotte", "state": "North Carolina", "zip": "28204", "country": "United States", "geoPoint": {"lat": 35.22709, "lon": -80.84313}}, {"facility": "Medical Research Unlimited, Inc.", "city": "Cincinnati", "state": "Ohio", "zip": "45242", "country": "United States", "geoPoint": {"lat": 39.12713, "lon": -84.51435}}, {"facility": "Lion Research", "city": "Norman", "state": "Oklahoma", "zip": "73069", "country": "United States", "geoPoint": {"lat": 35.22257, "lon": -97.43948}}, {"facility": "Lynn Institute of Norman", "city": "Norman", "state": "Oklahoma", "zip": "73069", "country": "United States", "geoPoint": {"lat": 35.22257, "lon": -97.43948}}, {"facility": "Integrated Medical Group Pc / Fleetwood Medical Assoc.", "city": "Fleetwood", "state": "Pennsylvania", "zip": "19522", "country": "United States", "geoPoint": {"lat": 40.45398, "lon": -75.81798}}, {"facility": "Palmetto Clinical Trial Services Llc", "city": "Fountain Inn", "state": "South Carolina", "zip": "29644", "country": "United States", "geoPoint": {"lat": 34.68901, "lon": -82.19567}}, {"facility": "Holston Medical Group", "city": "Bristol", "state": "Tennessee", "zip": "37620", "country": "United States", "geoPoint": {"lat": 36.59511, "lon": -82.18874}}, {"facility": "Dallas Diabetes & Endocrine Center", "city": "Dallas", "state": "Texas", "zip": "75230", "country": "United States", "geoPoint": {"lat": 32.78306, "lon": -96.80667}}, {"facility": "Covenant Clinical Research, Pa", "city": "San Antonio", "state": "Texas", "zip": "78229", "country": "United States", "geoPoint": {"lat": 29.42412, "lon": -98.49363}}, {"facility": "Independence Family Medicine", "city": "Virginia Beach", "state": "Virginia", "zip": "23455", "country": "United States", "geoPoint": {"lat": 36.85293, "lon": -75.97799}}, {"facility": "Local Institution", "city": "Edmonton", "state": "Alberta", "zip": "T5A 4L8", "country": "Canada", "geoPoint": {"lat": 53.55014, "lon": -113.46871}}, {"facility": "Local Institution", "city": "Winnipeg", "state": "Manitoba", "zip": "R2V 4W3", "country": "Canada", "geoPoint": {"lat": 49.8844, "lon": -97.14704}}, {"facility": "Local Institution", "city": "Brampton", "state": "Ontario", "zip": "L6T 0G1", "country": "Canada", "geoPoint": {"lat": 43.68341, "lon": -79.76633}}, {"facility": "Local Institution", "city": "Burlington", "state": "Ontario", "zip": "L7M 4YI", "country": "Canada", "geoPoint": {"lat": 43.38621, "lon": -79.83713}}, {"facility": "Local Institution", "city": "Collingwood", "state": "Ontario", "zip": "L9Y 1W3", "country": "Canada", "geoPoint": {"lat": 44.4834, "lon": -80.21638}}, {"facility": "Local Institution", "city": "London", "state": "Ontario", "zip": "N6H 0G6", "country": "Canada", "geoPoint": {"lat": 42.98339, "lon": -81.23304}}, {"facility": "Local Institution", "city": "Newmarket", "state": "Ontario", "zip": "L3Y 5G8", "country": "Canada", "geoPoint": {"lat": 44.05011, "lon": -79.46631}}, {"facility": "Local Institution", "city": "Toronto", "state": "Ontario", "zip": "M9V 4B4", "country": "Canada", "geoPoint": {"lat": 43.70011, "lon": -79.4163}}, {"facility": "Local Institution", "city": "Toronto", "state": "Ontario", "zip": "M9W 4L6", "country": "Canada", "geoPoint": {"lat": 43.70011, "lon": -79.4163}}, {"facility": "Local Institution", "city": "London", "zip": "N5W 6A2", "country": "Canada", "geoPoint": {"lat": 42.98339, "lon": -81.23304}}, {"facility": "Local Institution", "city": "Quebec", "zip": "G1N 4V3", "country": "Canada", "geoPoint": {"lat": 46.81228, "lon": -71.21454}}, {"facility": "Local Institution", "city": "Brno", "zip": "636 00", "country": "Czechia", "geoPoint": {"lat": 49.19522, "lon": 16.60796}}, {"facility": "Local Institution", "city": "Ceske Budejovice", "zip": "370 01", "country": "Czechia", "geoPoint": {"lat": 48.97447, "lon": 14.47434}}, {"facility": "Local Institution", "city": "Krnov", "zip": "794 01", "country": "Czechia", "geoPoint": {"lat": 50.08967, "lon": 17.70385}}, {"facility": "Local Institution", "city": "Liberec", "zip": "460 01", "country": "Czechia", "geoPoint": {"lat": 50.76711, "lon": 15.05619}}, {"facility": "Local Institution", "city": "Litomysl", "zip": "570 14", "country": "Czechia", "geoPoint": {"lat": 49.86809, "lon": 16.31298}}, {"facility": "Local Institution", "city": "Novy Jicin", "zip": "741 01", "country": "Czechia", "geoPoint": {"lat": 49.59438, "lon": 18.01028}}, {"facility": "Local Institution", "city": "Ostrava - Kuncice", "zip": "719 00", "country": "Czechia", "geoPoint": {"lat": 49.7903, "lon": 18.2919}}, {"facility": "Local Institution", "city": "Praha 10", "zip": "100 00", "country": "Czechia", "geoPoint": {"lat": 50.08804, "lon": 14.42076}}, {"facility": "Local Institution", "city": "Praha 1", "zip": "11694", "country": "Czechia", "geoPoint": {"lat": 50.08804, "lon": 14.42076}}, {"facility": "Local Institution", "city": "Praha 5", "zip": "15000", "country": "Czechia", "geoPoint": {"lat": 50.08804, "lon": 14.42076}}, {"facility": "Local Institution", "city": "Aschaffenburg", "state": "Bayern", "zip": "63739", "country": "Germany", "geoPoint": {"lat": 49.97704, "lon": 9.15214}}, {"facility": "Local Institution", "city": "Munster", "state": "Nordrhein-Westfalen", "zip": "48145", "country": "Germany", "geoPoint": {"lat": 51.96236, "lon": 7.62571}}, {"facility": "Local Institution", "city": "Leipzig", "state": "Saxony", "zip": "04249", "country": "Germany", "geoPoint": {"lat": 51.33962, "lon": 12.37129}}, {"facility": "Local Institution", "city": "Berlin", "zip": "12157", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Local Institution", "city": "Heidelberg", "zip": "69115", "country": "Germany", "geoPoint": {"lat": 49.40768, "lon": 8.69079}}, {"facility": "Local Institution", "city": "Leipzig", "country": "Germany", "geoPoint": {"lat": 51.33962, "lon": 12.37129}}, {"facility": "Local Institution", "city": "Lohne", "zip": "32584", "country": "Germany", "geoPoint": {"lat": 52.18848, "lon": 8.6922}}, {"facility": "Local Institution", "city": "Myen", "zip": "56727", "country": "Germany"}, {"facility": "Local Institution", "city": "Papenburg", "zip": "D-26871", "country": "Germany", "geoPoint": {"lat": 53.07738, "lon": 7.40444}}, {"facility": "Local Institution", "city": "Pirna", "zip": "01796", "country": "Germany", "geoPoint": {"lat": 50.95843, "lon": 13.93702}}, {"facility": "Local Institution", "city": "Pecs", "state": "Baranya", "zip": "7623", "country": "Hungary", "geoPoint": {"lat": 46.08333, "lon": 18.23333}}, {"facility": "Local Institution", "city": "Szigetvar", "state": "Baranya", "zip": "7900", "country": "Hungary", "geoPoint": {"lat": 46.04865, "lon": 17.80554}}, {"facility": "Local Institution", "city": "Satoraljaujhely", "state": "Borsod-Abauj-Zemplen", "zip": "3980", "country": "Hungary", "geoPoint": {"lat": 48.39492, "lon": 21.65871}}, {"facility": "Local Institution", "city": "Hodmezvasarhely", "state": "Csongrad", "zip": "6800", "country": "Hungary"}, {"facility": "Local Institution", "city": "Nyiregyhaza", "state": "Szabolcs-Szatmar-Bereg", "zip": "4400", "country": "Hungary", "geoPoint": {"lat": 47.95539, "lon": 21.71671}}, {"facility": "Local Institution", "city": "Nyiregyhaza", "state": "Szabolcs-Szatmar-Bereg", "zip": "4405", "country": "Hungary", "geoPoint": {"lat": 47.95539, "lon": 21.71671}}, {"facility": "Local Institution", "city": "Budapest", "zip": "100036", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"facility": "Local Institution", "city": "Budapest", "zip": "1033", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"facility": "Local Institution", "city": "Budapest", "zip": "1083", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"facility": "Local Institution", "city": "Budapest", "zip": "1097", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"facility": "Local Institution", "city": "Budapest", "zip": "1183", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"facility": "Local Institution", "city": "Budapest", "zip": "1212", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"facility": "Local Institution", "city": "Csorna", "zip": "9300", "country": "Hungary", "geoPoint": {"lat": 47.61155, "lon": 17.25012}}, {"facility": "Local Institution", "city": "Debrecen", "zip": "4025", "country": "Hungary", "geoPoint": {"lat": 47.53333, "lon": 21.63333}}, {"facility": "Local Institution", "city": "Kecskemet", "zip": "6000", "country": "Hungary", "geoPoint": {"lat": 46.90618, "lon": 19.69128}}, {"facility": "Local Institution", "city": "Mosonmagyarovar", "zip": "9200", "country": "Hungary", "geoPoint": {"lat": 47.86789, "lon": 17.26994}}, {"facility": "Local Institution", "city": "Nagykanizsa", "zip": "8800", "country": "Hungary", "geoPoint": {"lat": 46.45347, "lon": 16.99104}}, {"facility": "Local Institution", "city": "Oroshaza", "zip": "5900", "country": "Hungary", "geoPoint": {"lat": 46.56667, "lon": 20.66667}}, {"facility": "Local Institution", "city": "Szekesfehervar", "zip": "8000", "country": "Hungary", "geoPoint": {"lat": 47.18995, "lon": 18.41034}}, {"facility": "Local Institution", "city": "Szentes", "zip": "6600", "country": "Hungary", "geoPoint": {"lat": 46.65628, "lon": 20.27194}}, {"facility": "Local Institution", "city": "Szobathely", "zip": "H-9700", "country": "Hungary"}, {"facility": "Local Institution", "city": "Gdansk", "state": "Pomorskie", "zip": "80-546", "country": "Poland", "geoPoint": {"lat": 54.35205, "lon": 18.64637}}, {"facility": "Local Institution", "city": "Katowice", "state": "Slaskie", "zip": "40-752", "country": "Poland", "geoPoint": {"lat": 50.25841, "lon": 19.02754}}, {"facility": "Local Institution", "city": "Bialystok", "zip": "15-276", "country": "Poland", "geoPoint": {"lat": 53.13333, "lon": 23.16433}}, {"facility": "Local Institution", "city": "Bialystok", "zip": "15-435", "country": "Poland", "geoPoint": {"lat": 53.13333, "lon": 23.16433}}, {"facility": "Local Institution", "city": "Krakow", "zip": "31-024", "country": "Poland", "geoPoint": {"lat": 50.06143, "lon": 19.93658}}, {"facility": "Local Institution", "city": "Krakow", "zip": "31261", "country": "Poland", "geoPoint": {"lat": 50.06143, "lon": 19.93658}}, {"facility": "Local Institution", "city": "Lublin", "zip": "20-090", "country": "Poland", "geoPoint": {"lat": 51.25, "lon": 22.56667}}, {"facility": "Local Institution", "city": "Lublin", "zip": "20-538", "country": "Poland", "geoPoint": {"lat": 51.25, "lon": 22.56667}}, {"facility": "Local Institution", "city": "Poznan", "zip": "61-655", "country": "Poland", "geoPoint": {"lat": 52.40692, "lon": 16.92993}}, {"facility": "Local Institution", "city": "Zamosc", "country": "Poland", "geoPoint": {"lat": 50.72314, "lon": 23.25196}}, {"facility": "Fb Med Research, Psc", "city": "Caguas", "zip": "00725", "country": "Puerto Rico", "geoPoint": {"lat": 18.23412, "lon": -66.0485}}, {"facility": "Local Institution", "city": "Caguas", "zip": "00725", "country": "Puerto Rico", "geoPoint": {"lat": 18.23412, "lon": -66.0485}}, {"facility": "Local Institution", "city": "Carolina", "zip": "00983", "country": "Puerto Rico", "geoPoint": {"lat": 18.38078, "lon": -65.95739}}, {"facility": "Policlinica Dr. Luis Rodriguez", "city": "Carolina", "zip": "00983", "country": "Puerto Rico", "geoPoint": {"lat": 18.38078, "lon": -65.95739}}, {"facility": "Local Institution", "city": "Las Lomas", "zip": "00921", "country": "Puerto Rico"}, {"facility": "Luis Rivera-Colon, Md", "city": "Las Lomas", "zip": "00921", "country": "Puerto Rico"}, {"facility": "Local Institution", "city": "Ponce", "zip": "00716", "country": "Puerto Rico", "geoPoint": {"lat": 18.01108, "lon": -66.61406}}, {"facility": "Ponce School Of Medicine", "city": "Ponce", "zip": "00716", "country": "Puerto Rico", "geoPoint": {"lat": 18.01108, "lon": -66.61406}}, {"facility": "Local Institution", "city": "Ponce", "zip": "00717", "country": "Puerto Rico", "geoPoint": {"lat": 18.01108, "lon": -66.61406}}, {"facility": "Research & Cardiovascular Corp", "city": "Ponce", "zip": "00717", "country": "Puerto Rico", "geoPoint": {"lat": 18.01108, "lon": -66.61406}}, {"facility": "Caparra Internal Med Res Ctr", "city": "Rio Grande", "zip": "00745", "country": "Puerto Rico", "geoPoint": {"lat": 18.38023, "lon": -65.83127}}, {"facility": "Local Institution", "city": "Rio Grande", "zip": "00745", "country": "Puerto Rico", "geoPoint": {"lat": 18.38023, "lon": -65.83127}}, {"facility": "Altamira Family Medicine And Research Institute", "city": "San Juan", "zip": "00920", "country": "Puerto Rico", "geoPoint": {"lat": 18.46633, "lon": -66.10572}}, {"facility": "Local Institution", "city": "San Juan", "zip": "00920", "country": "Puerto Rico", "geoPoint": {"lat": 18.46633, "lon": -66.10572}}, {"facility": "Local Institution", "city": "San Juan", "zip": "00926-2832", "country": "Puerto Rico", "geoPoint": {"lat": 18.46633, "lon": -66.10572}}, {"facility": "The Office Of Miguel Sosa-Padilla, Md", "city": "San Juan", "zip": "00926", "country": "Puerto Rico", "geoPoint": {"lat": 18.46633, "lon": -66.10572}}, {"facility": "Local Institution", "city": "Alba Iulia", "zip": "510053", "country": "Romania", "geoPoint": {"lat": 46.06667, "lon": 23.58333}}, {"facility": "Local Institution", "city": "Bacau", "zip": "600114", "country": "Romania", "geoPoint": {"lat": 46.56718, "lon": 26.91384}}, {"facility": "Local Institution", "city": "Bacau", "zip": "600164", "country": "Romania", "geoPoint": {"lat": 46.56718, "lon": 26.91384}}, {"facility": "Local Institution", "city": "Baia Mare", "zip": "430123", "country": "Romania", "geoPoint": {"lat": 47.65529, "lon": 23.57381}}, {"facility": "Local Institution", "city": "Brasov", "zip": "500283", "country": "Romania", "geoPoint": {"lat": 45.64861, "lon": 25.60613}}, {"facility": "Local Institution", "city": "Brasov", "zip": "500365", "country": "Romania", "geoPoint": {"lat": 45.64861, "lon": 25.60613}}, {"facility": "Local Institution", "city": "Bucharest", "zip": "011234", "country": "Romania", "geoPoint": {"lat": 44.43225, "lon": 26.10626}}, {"facility": "Local Institution", "city": "Bucuresti", "zip": "010507", "country": "Romania", "geoPoint": {"lat": 44.42802, "lon": 26.09665}}, {"facility": "Local Institution", "city": "Bucuresti", "zip": "014461", "country": "Romania", "geoPoint": {"lat": 44.42802, "lon": 26.09665}}, {"facility": "Local Institution", "city": "Bucuresti", "zip": "050538", "country": "Romania", "geoPoint": {"lat": 44.42802, "lon": 26.09665}}, {"facility": "Local Institution", "city": "Bucuresti", "zip": "050722", "country": "Romania", "geoPoint": {"lat": 44.42802, "lon": 26.09665}}, {"facility": "Local Institution", "city": "Constanta", "zip": "900675", "country": "Romania", "geoPoint": {"lat": 44.18073, "lon": 28.63432}}, {"facility": "Local Institution", "city": "Ploiesti", "zip": "100683", "country": "Romania", "geoPoint": {"lat": 44.95, "lon": 26.01667}}, {"facility": "Local Institution", "city": "Satu Mare", "zip": "440055", "country": "Romania", "geoPoint": {"lat": 47.79926, "lon": 22.86255}}, {"facility": "Local Institution", "city": "Tg Mures", "zip": "540142", "country": "Romania"}, {"facility": "Local Institution", "city": "Mthatha", "state": "Eastern CAPE", "zip": "5099", "country": "South Africa", "geoPoint": {"lat": -31.58893, "lon": 28.78443}}, {"facility": "Local Institution", "city": "Port Elizabeth", "state": "Eastern CAPE", "zip": "6014", "country": "South Africa", "geoPoint": {"lat": -33.91799, "lon": 25.57007}}, {"facility": "Local Institution", "city": "Welkom", "state": "FREE State", "zip": "9460", "country": "South Africa", "geoPoint": {"lat": -27.97742, "lon": 26.73506}}, {"facility": "Local Institution", "city": "Lyttelton", "state": "Gauteng", "zip": "0157", "country": "South Africa", "geoPoint": {"lat": -25.82988, "lon": 28.2012}}, {"facility": "Local Institution", "city": "Pretoria", "state": "Gauteng", "zip": "0002", "country": "South Africa", "geoPoint": {"lat": -25.74486, "lon": 28.18783}}, {"facility": "Local Institution", "city": "Pretoria", "state": "Gauteng", "zip": "0101", "country": "South Africa", "geoPoint": {"lat": -25.74486, "lon": 28.18783}}, {"facility": "Local Institution", "city": "Durban", "state": "Kwazulu-Natal", "zip": "4091", "country": "South Africa", "geoPoint": {"lat": -29.8579, "lon": 31.0292}}, {"facility": "Local Institution", "city": "Phoenix, Durban", "state": "Kwazulu-Natal", "zip": "4068", "country": "South Africa"}, {"facility": "Local Institution", "city": "Brits", "state": "North-West", "zip": "0250", "country": "South Africa", "geoPoint": {"lat": -25.63473, "lon": 27.78022}}, {"facility": "Local Institution", "city": "Cape Town", "state": "Western CAPE", "zip": "7460", "country": "South Africa", "geoPoint": {"lat": -33.92584, "lon": 18.42322}}, {"facility": "Local Institution", "city": "Worcester", "state": "Western CAPE", "zip": "6850", "country": "South Africa", "geoPoint": {"lat": -33.64651, "lon": 19.44852}}, {"facility": "Local Institution", "city": "Potchefstroom", "zip": "2531", "country": "South Africa", "geoPoint": {"lat": -26.71667, "lon": 27.1}}, {"facility": "Local Institution", "city": "Monifieth", "state": "AFO", "zip": "DD5 4LX", "country": "United Kingdom", "geoPoint": {"lat": 56.48227, "lon": -2.81732}}, {"facility": "Local Institution", "city": "Carmarthen", "state": "CAT", "zip": "SA31 2AF", "country": "United Kingdom", "geoPoint": {"lat": 51.85552, "lon": -4.30535}}, {"facility": "Local Institution", "city": "Fife", "state": "FIF", "zip": "KY14 7AW", "country": "United Kingdom"}, {"facility": "Local Institution", "city": "Chippenham", "state": "Wiltshire", "zip": "SN15 2SB", "country": "United Kingdom", "geoPoint": {"lat": 51.46, "lon": -2.12472}}, {"facility": "Local Institution", "city": "Chippenham", "state": "WLT", "zip": "SN14 6GT", "country": "United Kingdom", "geoPoint": {"lat": 51.46, "lon": -2.12472}}, {"facility": "Local Institution", "city": "Addlestone", "zip": "KT15 2BH", "country": "United Kingdom", "geoPoint": {"lat": 51.37135, "lon": -0.49353}}, {"facility": "Local Institution", "city": "Bath", "zip": "BA1 3NG", "country": "United Kingdom", "geoPoint": {"lat": 51.3751, "lon": -2.36172}}, {"facility": "Local Institution", "city": "Cardenden Fife", "zip": "KY5 0JE", "country": "United Kingdom"}, {"facility": "Local Institution", "city": "Dundee", "zip": "DD2 5NH", "country": "United Kingdom", "geoPoint": {"lat": 56.46913, "lon": -2.97489}}, {"facility": "Local Institution", "city": "Dundee", "zip": "DD4 6RD", "country": "United Kingdom", "geoPoint": {"lat": 56.46913, "lon": -2.97489}}, {"facility": "Local Institution", "city": "Manchester", "zip": "M23 9LT", "country": "United Kingdom", "geoPoint": {"lat": 53.48095, "lon": -2.23743}}, {"facility": "Local Institution", "city": "Nuneaton", "zip": "CV10 7DJ", "country": "United Kingdom", "geoPoint": {"lat": 52.52323, "lon": -1.46523}}]}, "referencesModule": {"seeAlsoLinks": [{"label": "BMS Clinical Trial Information", "url": "https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html"}, {"label": "BMS clinical trial educational resource", "url": "https://www.bmsstudyconnect.com/s/US/English/USenHome"}, {"label": "FDA Safety Alerts and Recalls", "url": "https://www.fda.gov/Safety/MedWatch/SafetyInformation/default.htm"}]}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "570 completed lead-in period and were eligible for randomization. 568 randomized. Non-randomized: 1 AE, 27 WC, 3 lost to FU, 7 NC, 159 SC, 8 ARS, 3 other.", "recruitmentDetails": "1736 enrolled at 148 study sites in North America, Europe, and South Africa.Lead in period=794. Reasons not entered: 1 AE, 17 WC, 4 lost to FU, 3 NC, 911 SC, 4 ARS, 1 other. Adverse event=-AE, Withdrew consent=WC, Follow-up=FU, poor/non-compliance=NC, No longer met study criteria=SC, Administrative reason by sponsor=ARS.", "groups": [{"id": "FG000", "title": "Metformin XR", "description": "Participants received Metformin XR and Placebo matching with Metformin XR\n\nMetformin Extended Release (XR) 500 mg tablets (500-2000 mg per day) by mouth twice daily (BID) for 24 weeks\n\nPlacebo matching with Metformin XR 0 mg tablets by mouth twice daily (BID) for 24 weeks."}, {"id": "FG001", "title": "Metformin IR", "description": "Participants received Metformin IR and Placebo matching with Metformin IR.\n\nMetformin Immediate Release (IR) 500 mg tablets (500-2000 mg per day) by mouth twice daily (BID) for 24 weeks\n\nPlacebo matching with Metformin IR 0 mg tablets by mouth twice daily (BID) for 24 weeks."}], "periods": [{"title": "Double Blind Treatment - All Treated", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "283"}, {"groupId": "FG001", "numSubjects": "285"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "268"}, {"groupId": "FG001", "numSubjects": "271"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "15"}, {"groupId": "FG001", "numSubjects": "14"}]}], "dropWithdraws": [{"type": "Removed due to site non-compliance", "reasons": [{"groupId": "FG000", "numSubjects": "15"}, {"groupId": "FG001", "numSubjects": "14"}]}]}, {"title": "Double Blind - Compliant Randomized", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "268"}, {"groupId": "FG001", "numSubjects": "271"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "245"}, {"groupId": "FG001", "numSubjects": "245"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "23"}, {"groupId": "FG001", "numSubjects": "26"}]}], "dropWithdraws": [{"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "6"}, {"groupId": "FG001", "numSubjects": "1"}]}, {"type": "Subject Request to Discontinue Treatment", "reasons": [{"groupId": "FG000", "numSubjects": "2"}, {"groupId": "FG001", "numSubjects": "0"}]}, {"type": "Subject Withdrew Consent", "reasons": [{"groupId": "FG000", "numSubjects": "4"}, {"groupId": "FG001", "numSubjects": "5"}]}, {"type": "Death", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "0"}]}, {"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "3"}, {"groupId": "FG001", "numSubjects": "10"}]}, {"type": "Poor/Non-compliance", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "0"}]}, {"type": "Other", "reasons": [{"groupId": "FG000", "numSubjects": "6"}, {"groupId": "FG001", "numSubjects": "10"}]}]}, {"title": "Off Treatment Follow-Up", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "9"}, {"groupId": "FG001", "numSubjects": "1"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "6"}, {"groupId": "FG001", "numSubjects": "1"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "3"}, {"groupId": "FG001", "numSubjects": "0"}]}], "dropWithdraws": [{"type": "Other", "reasons": [{"groupId": "FG000", "numSubjects": "2"}, {"groupId": "FG001", "numSubjects": "0"}]}, {"type": "Subject Withdrew Consent", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"populationDescription": "All Treated Data Set (n=568) are the randomized participants who received at least 1 dose of study drug during the double blind treatment period (up to rescue). 29 participants were excluded from the baseline Randomized Data Set; therefore, the number of participants included in the baseline population is 539. n = number of evaluable participants", "groups": [{"id": "BG000", "title": "Metformin XR", "description": "Participants received Metformin XR and Placebo matching with Metformin XR\n\nMetformin Extended Release (XR) 500 mg tablets (500-2000 mg per day) by mouth twice daily (BID) for 24 weeks\n\nPlacebo matching with Metformin XR 0 mg tablets by mouth twice daily (BID) for 24 weeks."}, {"id": "BG001", "title": "Metformin IR", "description": "Participants received Metformin IR and Placebo matching with Metformin IR.\n\nMetformin Immediate Release (IR) 500 mg tablets (500-2000 mg per day) by mouth twice daily (BID) for 24 weeks\n\nPlacebo matching with Metformin IR 0 mg tablets by mouth twice daily (BID) for 24 weeks."}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "268"}, {"groupId": "BG001", "value": "271"}, {"groupId": "BG002", "value": "539"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "56.8", "spread": "10.69"}, {"groupId": "BG001", "value": "55.3", "spread": "10.34"}, {"groupId": "BG002", "value": "56.0", "spread": "10.53"}]}]}]}, {"title": "Age, Customized", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "< 65 years", "categories": [{"measurements": [{"groupId": "BG000", "value": "198"}, {"groupId": "BG001", "value": "226"}, {"groupId": "BG002", "value": "424"}]}]}, {"title": ">= 65 years", "categories": [{"measurements": [{"groupId": "BG000", "value": "70"}, {"groupId": "BG001", "value": "45"}, {"groupId": "BG002", "value": "115"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "122"}, {"groupId": "BG001", "value": "122"}, {"groupId": "BG002", "value": "244"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "146"}, {"groupId": "BG001", "value": "149"}, {"groupId": "BG002", "value": "295"}]}]}]}, {"title": "Race/Ethnicity, Customized", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "White", "categories": [{"measurements": [{"groupId": "BG000", "value": "227"}, {"groupId": "BG001", "value": "225"}, {"groupId": "BG002", "value": "452"}]}]}, {"title": "Black or African American", "categories": [{"measurements": [{"groupId": "BG000", "value": "22"}, {"groupId": "BG001", "value": "19"}, {"groupId": "BG002", "value": "41"}]}]}, {"title": "Asian", "categories": [{"measurements": [{"groupId": "BG000", "value": "17"}, {"groupId": "BG001", "value": "20"}, {"groupId": "BG002", "value": "37"}]}]}, {"title": "Other", "categories": [{"measurements": [{"groupId": "BG000", "value": "2"}, {"groupId": "BG001", "value": "7"}, {"groupId": "BG002", "value": "9"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Adjusted Mean Change From Baseline in HbA1c", "description": "Mean change in glycated hemoglobin (HbA1c) from baseline to Week 24 in the double-blind treatment period.", "populationDescription": "Randomized participants who took at least one dose of double-blind study medication in the treatment group to which they were randomized with non-missing baseline and Week 24 values who were not excluded due to non-compliance.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "percent", "timeFrame": "Baseline and Week 24", "groups": [{"id": "OG000", "title": "Metformin XR", "description": "Participants received Metformin XR and Placebo matching with Metformin XR\n\nMetformin Extended Release (XR) 500 mg tablets (500-2000 mg per day) by mouth twice daily (BID) for 24 weeks\n\nPlacebo matching with Metformin XR 0 mg tablets by mouth twice daily (BID) for 24 weeks."}, {"id": "OG001", "title": "Metformin IR", "description": "Participants received Metformin IR and Placebo matching with Metformin IR.\n\nMetformin Immediate Release (IR) 500 mg tablets (500-2000 mg per day) by mouth twice daily (BID) for 24 weeks\n\nPlacebo matching with Metformin IR 0 mg tablets by mouth twice daily (BID) for 24 weeks."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "237"}, {"groupId": "OG001", "value": "237"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.93", "spread": "0.0485", "lowerLimit": "-1.02", "upperLimit": "-0.83"}, {"groupId": "OG001", "value": "-0.96", "spread": "0.0480", "lowerLimit": "-1.05", "upperLimit": "-0.87"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "nonInferiorityType": "NON_INFERIORITY_OR_EQUIVALENCE_LEGACY", "nonInferiorityComment": "The study provided 90% power to demonstrate noninferiority in change from baseline mean HbA1c at Week 24, with an assumed standard deviation (SD) of 1.0%, a non-inferiority margin of 0.3%, and 2-sided alpha of 0.05 for the primary comparison", "paramType": "Mean Difference (Final Values)", "paramValue": "0.03", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.10", "ciUpperLimit": "0.17", "dispersionType": "STANDARD_ERROR_OF_MEAN", "dispersionValue": "0.0687", "estimateComment": "METFORMIN XR VS METFORMIN IR"}]}, {"type": "SECONDARY", "title": "Mean Change in Fasting Plasma Glucose (FPG)", "description": "The mean change in fasting plasma glucose (FPG) from baseline to Week 24 in the double-blind treatment period was assessed. The lack of glycemic control criteria for initiation of rescue medication during Week 12 to Week 24 was having a FPG \\> 200 mg/dL (11.1 mmol/L). mg/dL = milligrams per deciliter; mmol/L = millimole per Liter", "populationDescription": "Randomized participants who took at least one dose of double-blind study medication in the treatment group to which they were randomized with non-missing baseline and Week 24 values and who were not excluded due to non-compliance.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "mg/dL", "timeFrame": "Baseline and Week 24", "groups": [{"id": "OG000", "title": "Metformin XR", "description": "Participants received Metformin XR and Placebo matching with Metformin XR\n\nMetformin Extended Release (XR) 500 mg tablets (500-2000 mg per day) by mouth twice daily (BID) for 24 weeks\n\nPlacebo matching with Metformin XR 0 mg tablets by mouth twice daily (BID) for 24 weeks."}, {"id": "OG001", "title": "Metformin IR", "description": "Participants received Metformin IR and Placebo matching with Metformin IR.\n\nMetformin Immediate Release (IR) 500 mg tablets (500-2000 mg per day) by mouth twice daily (BID) for 24 weeks\n\nPlacebo matching with Metformin IR 0 mg tablets by mouth twice daily (BID) for 24 weeks."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "228"}, {"groupId": "OG001", "value": "229"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-21.1", "spread": "1.803"}, {"groupId": "OG001", "value": "-20.6", "spread": "1.789"}]}]}]}, {"type": "SECONDARY", "title": "Mean Change in Mean Daily Glucose (MDG)", "description": "The mean change in Mean Daily Glucose (MDG) from baseline to Week 24 in the double-blind treatment period was assessed. Prior to the Day 1 visit (between Week -1 and Day 1) and in the week before the Week 24/Study Termination and Rescue or Early Treatment Termination visit, participants performed 7-point finger stick blood glucose monitoring (before and 2 hours after 3 meals per day, and at bedtime) for 3 consecutive days in order to determine their MDG.", "populationDescription": "Randomized participants who took at least one dose of double-blind study medication in the treatment group to which they were randomized with non-missing baseline and Week 24 last observation carried forward (LOCF) results who were not excluded due to non-compliance.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "mg/dL", "timeFrame": "Baseline and Week 24", "groups": [{"id": "OG000", "title": "Metformin XR", "description": "Participants received Metformin XR and Placebo matching with Metformin XR\n\nMetformin Extended Release (XR) 500 mg tablets (500-2000 mg per day) by mouth twice daily (BID) for 24 weeks\n\nPlacebo matching with Metformin XR 0 mg tablets by mouth twice daily (BID) for 24 weeks."}, {"id": "OG001", "title": "Metformin IR", "description": "Participants received Metformin IR and Placebo matching with Metformin IR.\n\nMetformin Immediate Release (IR) 500 mg tablets (500-2000 mg per day) by mouth twice daily (BID) for 24 weeks\n\nPlacebo matching with Metformin IR 0 mg tablets by mouth twice daily (BID) for 24 weeks."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "211"}, {"groupId": "OG001", "value": "218"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-24.68", "spread": "1.5813"}, {"groupId": "OG001", "value": "-27.05", "spread": "1.555"}]}]}]}, {"type": "SECONDARY", "title": "Percent of Participants With HbA1c < 7%", "description": "Percent of participants achieving a therapeutic glycemic response (defined as HbA1c \\< 7.0%) at Week 24 in the double-blind treatment period.", "populationDescription": "Randomized participants who took at least one dose of double-blind study medication in the treatment group to which they were randomized with non-missing baseline and Week 24 values who were not excluded due to non-compliance.", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "percent of participants", "timeFrame": "Week 24", "groups": [{"id": "OG000", "title": "Metformin XR", "description": "Participants received Metformin XR and Placebo matching with Metformin XR\n\nMetformin Extended Release (XR) 500 mg tablets (500-2000 mg per day) by mouth twice daily (BID) for 24 weeks\n\nPlacebo matching with Metformin XR 0 mg tablets by mouth twice daily (BID) for 24 weeks."}, {"id": "OG001", "title": "Metformin IR", "description": "Participants received Metformin IR and Placebo matching with Metformin IR.\n\nMetformin Immediate Release (IR) 500 mg tablets (500-2000 mg per day) by mouth twice daily (BID) for 24 weeks\n\nPlacebo matching with Metformin IR 0 mg tablets by mouth twice daily (BID) for 24 weeks."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "237"}, {"groupId": "OG001", "value": "237"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "70.9", "lowerLimit": "65.5", "upperLimit": "76.3"}, {"groupId": "OG001", "value": "72.0", "lowerLimit": "66.3", "upperLimit": "77.7"}]}]}]}, {"type": "PRIMARY", "title": "Number of Participants With Death, Serious Adverse Events (SAEs), SAEs Related to Study Therapy, SAEs Leading to Discontinuation, Adverse Events (AEs) Related to Study Therapy, and AEs Leading to Discontinuation", "description": "SAE=a medical event that at any dose results in death, persistent or significant disability/incapacity, or drug dependency/abuse; is life-threatening, an important medical event, or a congenital anomaly/birth defect; or requires or prolongs hospitalization. AE=any new unfavorable symptom, sign, or disease or worsening of a preexisting condition that may not have a causal relationship with treatment. Treatment-related=having certain, probable, possible, or missing relationship to study drug. All listed events are treatment emergent, which is defined as nonserious and serious AEs with an onset from Day 1 of the double-blind treatment up to and including 4 days and 30 days respectively, after the last dose date of double-blind study. randomized.", "populationDescription": "Treated participants; All participants who took at least one dose of double-blind study medication in the treatment group they were randomized to unless participants had never received the double-blind study medication they were randomized. Those participants were included in the treatment group based on the first treatment received.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "Date of first dose (Day 1) up to 30 post last dose of study drug (approx. 28 weeks)", "groups": [{"id": "OG000", "title": "Metformin XR", "description": "Participants received Metformin XR and Placebo matching with Metformin XR\n\nMetformin Extended Release (XR) 500 mg tablets (500-2000 mg per day) by mouth twice daily (BID) for 24 weeks\n\nPlacebo matching with Metformin XR 0 mg tablets by mouth twice daily (BID) for 24 weeks."}, {"id": "OG001", "title": "Metformin IR", "description": "Participants received Metformin IR and Placebo matching with Metformin IR.\n\nMetformin Immediate Release (IR) 500 mg tablets (500-2000 mg per day) by mouth twice daily (BID) for 24 weeks\n\nPlacebo matching with Metformin IR 0 mg tablets by mouth twice daily (BID) for 24 weeks."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "283"}, {"groupId": "OG001", "value": "285"}]}], "classes": [{"title": "Death", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "0"}]}]}, {"title": "SAE", "categories": [{"measurements": [{"groupId": "OG000", "value": "8"}, {"groupId": "OG001", "value": "10"}]}]}, {"title": "SAEs Related to Study Therapy", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "1"}]}]}, {"title": "SAEs Leading to Discontinuation", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "1"}]}]}, {"title": "AEs Related to Study Therapy", "categories": [{"measurements": [{"groupId": "OG000", "value": "30"}, {"groupId": "OG001", "value": "25"}]}]}, {"title": "AEs Leading to Discontinuation", "categories": [{"measurements": [{"groupId": "OG000", "value": "10"}, {"groupId": "OG001", "value": "7"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "timeFrame": "From Day 1 up to 30 days post last dose (approx. 28 weeks)", "eventGroups": [{"id": "EG000", "title": "Metformin XR", "description": "Participants received Metformin XR and Placebo matching with Metformin XR\n\nMetformin Extended Release (XR) 500 mg tablets (500-2000 mg per day) by mouth twice daily (BID) for 24 weeks\n\nPlacebo matching with Metformin XR 0 mg tablets by mouth twice daily (BID) for 24 weeks.", "seriousNumAffected": 8, "seriousNumAtRisk": 283, "otherNumAffected": 25, "otherNumAtRisk": 283}, {"id": "EG001", "title": "Metformin IR", "description": "Participants received Metformin IR and Placebo matching with Metformin IR.\n\nMetformin Immediate Release (IR) 500 mg tablets (500-2000 mg per day) by mouth twice daily (BID) for 24 weeks\n\nPlacebo matching with Metformin IR 0 mg tablets by mouth twice daily (BID) for 24 weeks.", "seriousNumAffected": 10, "seriousNumAtRisk": 285, "otherNumAffected": 22, "otherNumAtRisk": 285}], "seriousEvents": [{"term": "Hypocoagulable state", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 283}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 285}]}, {"term": "Angina unstable", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 283}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 285}]}, {"term": "Diplopia", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 283}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 285}]}, {"term": "Abdominal pain lower", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 283}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 285}]}, {"term": "Upper gastrointestinal haemorrhage", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 283}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 285}]}, {"term": "Cholecystitis", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 283}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 285}]}, {"term": "Cholecystitis acute", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 283}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 285}]}, {"term": "Cholelithiasis", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 283}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 285}]}, {"term": "Pulmonary tuberculosis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 283}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 285}]}, {"term": "Respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 283}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 285}]}, {"term": "Delayed recovery from anaesthesia", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 283}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 285}]}, {"term": "Laceration", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 283}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 285}]}, {"term": "Overdose", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 283}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 285}]}, {"term": "Diabetes mellitus inadequate control", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 283}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 285}]}, {"term": "Malignant melanoma in situ", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 283}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 285}]}, {"term": "Prostatic adenoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 283}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 285}]}, {"term": "Squamous cell carcinoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 283}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 285}]}, {"term": "Cerebral haemorrhage", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 283}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 285}]}, {"term": "Cerebral infarction", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 283}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 285}]}, {"term": "Ureterolithiasis", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 283}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 285}]}], "otherEvents": [{"term": "Diarrhoea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 19.0", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 25, "numAtRisk": 283}, {"groupId": "EG001", "numAffected": 22, "numAtRisk": 285}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "Bristol-Myers Squibb Co. agreements with investigators vary; constant is our right to embargo communications regarding trial results prior to public release for a period \u226460 days from submittal for review. We will not prohibit investigators from publishing, but will prohibit the disclosure of previously undisclosed confidential information other than study results, and request postponement of single-center publications until after disclosure of the clinical trial's primary publication."}, "pointOfContact": {"title": "Bristol-Myers Squibb Study Director", "organization": "Bristol-Myers Squibb", "email": "Clinical.Trials@bms.com"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24", "removedCountries": ["Czech Republic"]}, "conditionBrowseModule": {"meshes": [{"id": "D000003920", "term": "Diabetes Mellitus"}, {"id": "D000003924", "term": "Diabetes Mellitus, Type 2"}], "ancestors": [{"id": "D000044882", "term": "Glucose Metabolism Disorders"}, {"id": "D000008659", "term": "Metabolic Diseases"}, {"id": "D000004700", "term": "Endocrine System Diseases"}], "browseLeaves": [{"id": "M7115", "name": "Diabetes Mellitus", "asFound": "Diabetes", "relevance": "HIGH"}, {"id": "M7119", "name": "Diabetes Mellitus, Type 2", "asFound": "Type 2 Diabetes", "relevance": "HIGH"}, {"id": "M11639", "name": "Metabolic Diseases", "relevance": "LOW"}, {"id": "M25403", "name": "Glucose Metabolism Disorders", "relevance": "LOW"}, {"id": "M7862", "name": "Endocrine System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC18", "name": "Nutritional and Metabolic Diseases"}, {"abbrev": "BC19", "name": "Gland and Hormone Related Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000008687", "term": "Metformin"}], "ancestors": [{"id": "D000007004", "term": "Hypoglycemic Agents"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}], "browseLeaves": [{"id": "M11667", "name": "Metformin", "asFound": "Assessment", "relevance": "HIGH"}, {"id": "M10054", "name": "Hypoglycemic Agents", "relevance": "LOW"}], "browseBranches": [{"abbrev": "Hypo", "name": "Hypoglycemic Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}